What is Neurobiological Technologies Price-to-Operating-Cash-Flow?
As of today (2024-05-02), Neurobiological Technologies's share price is $0.0005.
Neurobiological Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2009 was $-0.41. Hence, Neurobiological Technologies's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Neurobiological Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:
Neurobiological Technologies's Cash Flow from Operations per share for the
three
months ended in Sep. 2009 was $0.09.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2009 was $-0.41.
Neurobiological Technologies Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Neurobiological Technologies's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurobiological Technologies Price-to-Operating-Cash-Flow Chart
|
Neurobiological Technologies Annual Data
|
|
Trend |
Jun00 |
Jun01 |
Jun02 |
Jun03 |
Jun04 |
Jun05 |
Jun06 |
Jun07 |
Jun08 |
Jun09 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
8.80 |
- |
- |
- |
|
Neurobiological Technologies Quarterly Data
|
|
Dec04 |
Mar05 |
Jun05 |
Sep05 |
Dec05 |
Mar06 |
Jun06 |
Sep06 |
Dec06 |
Mar07 |
Jun07 |
Sep07 |
Dec07 |
Mar08 |
Jun08 |
Sep08 |
Dec08 |
Mar09 |
Jun09 |
Sep09 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Neurobiological Technologies's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Neurobiological Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurobiological Technologies's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Neurobiological Technologies's Price-to-Operating-Cash-Flow falls into.
Neurobiological Technologies Price-to-Operating-Cash-Flow Calculation
Neurobiological Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.0005 | / | -0.411 |
| = | |
Neurobiological Technologies's Share Price of today is $0.0005.
Neurobiological Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Neurobiological Technologies (Neurobiological Technologies) Business Description
Traded in Other Exchanges
N/A
Address
2010 Crow Canyon Place, Suite 100, San Ramon, CA, USA, 94583
Neurobiological Technologies Inc is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions.
Executives
| Ariel Warszawski |
10 percent owner |
C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176 |
| Ryan Heslop |
10 percent owner |
C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176 |
| Firefly Management Co Gp, Llc |
10 percent owner |
C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176 |
| Fvp Gp, Llc |
10 percent owner |
C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176 |
| Firefly Value Partners, Lp |
10 percent owner |
426 PINEVILLE ROAD, UNIT 1, NEWTOWN PA 18940 |
| Fvp Master Fund Lp |
10 percent owner |
FVP GP LLC, 551 FIFTH AVENUE, 36TH FLOOR, New York NY 10176 |
| John B Stuppin |
director |
|
| Abraham E Cohen |
director |
500 SEVENTH AVE 10TH FL, C/O AXONYX INC, NEW YORK NY 10018 |
| Abraham D Sofaer |
director |
HOOVER INSTITUTION, STANFORD UNIVERSITY, STANFORD CA 94305-6010 |
| Biotechnology Value Fund L P |
other: Direct Beneficial Owner |
44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104 |
| Bvf Partners L P/il |
10 percent owner |
44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
| Bvf Inc/il |
10 percent owner |
44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104 |
| Biotechnology Value Fund Ii Lp |
other: Direct Beneficial Owner |
44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104 |
| Bvf Investments Llc |
other: Direct Beneficial Owner |
1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104 |
| Mark N Lampert |
10 percent owner |
1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104 |
Neurobiological Technologies (Neurobiological Technologies) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NTII has been successfully added to your